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EXPERIMENTAL STUDY
Effect of vitamins A, E, C and omega-3 fatty acids 
supplementation on the level of catalase and superoxide 
dismutase activities in streptozotocin-induced diabetic rats
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Sadeghi MR3, Mostafavi E4, Kargar F5 
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Abstract: Background: Since free radicals and antioxidant enzymes may play an important role in the develop-
ment of diabetes, the present study was designed to assess the effect of supplementation with vitamins A, E and 
C and ω-3 fatty acids on catalase and superoxide dismutase activity in streptozotocin (STZ)-induced diabetic rats.
Methods: A total of 64 male Wistar rats weighing 250 g were divided into four groups as normal control, diabetic 
control, diabetic supplemented with vitamin A, E and C and diabetic supplemented with ω-3 fatty acids. After 
four weeks the rats were anesthetized and catalase (CAT) and superoxide dismutase (SOD) activities were in-
vestigated in blood samples, liver and heart homogenates.
Results: In diabetic rats, the activity levels of heart SOD (p < 0.001) and heart and liver CAT (p < 0.001) were 
signifi cantly lower than in normal control rats. Supplementation with vitamins A, E and C signifi cantly increased 
heart CAT (p = 0.05). No signifi cant change was observed in diabetic rats supplemented with ω-3 fatty acids.
Conclusion: Supplementation with vitamins A, E and C and ω-3 fatty acids was found to increase heart CAT 
activity in diabetic rats and they can be valuable candidates in the treatment of the complications of diabetes 
(Tab. 6, Ref. 26). Text in PDF www.elis.sk.
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Introduction
Diabetes is widely known to induce metabolic derangement 
leading to oxidant-antioxidant imbalance. The putative role of 
reactive oxygen species (ROS) in the development of diabetic 
complications has been investigated for several decades  (1, 2). 
Propagation of lipid peroxidation is a degenerative process that 
affects cell membranes and other lipid-containing structures un-
der conditions of oxidative stress, often with cytopathological 
consequences  (3). Eukaryotic cells are equipped with a variety 
of primary and secondary defenses against the deleterious effects 
of oxidative stress. As lethal injury can occur when these defenses 
are overwhelmed, supplementation with antioxidant vitamins such 
as vitamins A, E and C may be benefi cial  (4). Vitamin E is a hy-
drophobic antioxidant found in lipoproteins and membranes and 
can afford primary as well as secondary stage protection. It is the 
most effi cient scavenger of lipid peroxyl radicals  (5). Vitamin C is 
a hydrophilic molecule that can scavenge several radicals, among 
them the hydroxyl radical. It is likely that vitamins E and C act in 
a synergistic manner, by vitamin E primarily being oxidized to the 
tocopheroxyl radical and then reduced back to tocopherol by vita-
min C  (6). Vitamin A plays an important role in insulin response 
as well  (7). Supplementation with ω-3 fatty acids can be useful 
to prevent diabetic complications. Long-chain ω-3 fatty acids are 
incorporated into cell membranes and have anti-infl ammatory 
properties that may be relevant for the prevention of type 1 dia-
betes, such as decreased expression of HLA class II molecules on 
activated human monocytes and reduced expression of interleu-
kin 1ß  (8, 9). The long-chain ω-3 fatty acids play an important 
role in eicosanoid metabolism, and there is evidence for aberrant 
prostaglandin metabolism in children with type 1 diabetes  (10). 
Taken together, these data suggest that anti-infl ammatory ω-3 fatty 
acids such as DHA and EPA may reduce the risk of disease devel-
opment. Thus the present study was designed to assess the effects 
of supplementation with vitamins A, E and C and ω-3 fatty acids 
on catalase and superoxide dismutase activities in the liver, heart 
and blood of streptozotocin-induced diabetic rats.
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Materials and methods
Animals and diets 
64 male Sprague-Dawley rats (15-wk-old) weighing 250 g 
were used in this study. The rats received standard chow diet and 
water ad libitum during the experimental period, and were main-
tained at an environmental temperature of 18–23 °C and 12-h light/
dark cycle. The rats were randomly divided into four groups of 16 
rats each, as normal control, diabetic control, diabetic rats supple-
mented with vitamins A, E and C and diabetic rats supplemented 
with ω-3 fatty acids. The rats in the normal control group received 
only standard diet and water. In the other three groups, diabetes 
was induced by intravascular injection of a single dose of STZ (40 
mg/kg body weight). Only those animals with blood glucose level 
over 300 mg/dl a week after injection were regarded diabetic. In 
the diabetic group supplemented with vitamins A, E and C each 
rat received 106 mg/kg vitamin A, 250 mg/kg vitamin E and 200 
mg/kg vitamin C daily by gavage. Each rat in the diabetic group 
supplemented with ω-3 fatty acids received a daily dose of 300 
mg/kg ω-3 fatty acids by gavage.
Tissue preparation
After four weeks of intervention, the rats were anesthetized and 
arterial blood samples were collected in EDTA-containing tubes. 
After centrifugation of blood samples at 2500 rpm for 5 minutes, 
the plasma was separated and erythrocytes were washed three times 
in 5 ml 9 % NaCl, total hemoglobin was measured and erythrocytes 
were stored at –70 °C until biochemical analysis. Liver and heart 
tissues were promptly excised and washed with physiological sa-
line, then dried by a fi lter paper and stored at –70 °C.
Preparation of tissue homogenate
For homogenate preparation to determine catalase and super-
oxide dismutase activities, 1:11 (W/V) tissue homogenate was 
prepared in 50 mM potassium phosphate buffer (pH 7.4), 150 mM 
KCl, and 200 mM EDTA by a Potter-Elvehjem tissue homogenizer 
and then centrifuged at 15000 rpm for 30 minutes. Protein con-
centration in the homogenate was determined by the Biuret assay 
using bovine serum albumin as standard  (11). 
Catalase activity
Catalase activity in liver and heart homogenates and erythro-
cytes was measured by Hygo Aebi method. In this method, the 
rate of hydrogen peroxide breakdown into water and oxygen is 
measured at 240 nm  (12). 
Superoxide dismutase activity
Superoxide dismutase activity in liver and heart homogenates 
and erythrocytes was measured with an indirect inhibition assay in 
which xanthine and xanthine oxidase produce superoxide radicals. 
Statistical analysis
All values are expressed as mean±SD. Independent sample t-
test was performed to compare the means of each two groups. A 
value of p < 0.05 was considered to be statistically signifi cant. All 
data were analyzed using Statistical Package for Social Sciences 
(version 11.5; SPSS Inc., Chicago, USA). 
Results
The values and statistical comparisons of catalase and su-
peroxide dismutase activity in experimental groups are shown in 
Tables 1 to 6. Catalase activity was signifi cantly decreased in the 
heart and liver of diabetic rats compared with control group (p < 
0.001). In addition, supplementation with vitamins A, E and C 
caused a signifi cant increase in heart catalase activity (p = 0.05). 
Supplementation with ω-3 fatty acids made no signifi cant change 
in catalase activity.
Superoxide dismutase activity was signifi cantly decreased in 
the heart of diabetic rats compared with control group (p < 0.001). 
Supplementation with vitamins A, E and C caused no signifi cant 
change in heart superoxide dismutase activity in diabetic rats. 
Supplementation with ω-3 fatty acids also made no signifi cant 
change in superoxide dismutase activity.
Sample Diabetic Control 
Group
Diabetic + 
Vitamins A, E, C 
Group
t-test Results
Erythrocyte lysate
(K/mg Hb) 133.08±21.81 141.05±22.91 p=0.32
Liver  
(K/mg protein) 281.87±76.38 315.98±70.43 p=0.19
Heart
(K/mg protein) 39.36±12.48 48.74±13.53 p=0.05
Data are presented as mean±SD. Each group contained 16 animals. The differences 
between groups were assessed by independent t-test. p < 0.05 considered signifi cant.
Tab. 2. Values and the statistical comparison of catalase activity in 
diabetic control and diabetic + vitamins A, E, C groups.
Tab. 1. Values and the statistical comparison of catalase activity in 
normal control and diabetic control groups.
Sample Normal Control 
Group
Diabetic Control 
Group
t-test Results
Erythrocyte lysate 
(K/mg Hb) 145.63±21.36 133.08±21.81 p= 0.110
Liver  
(K/mg protein) 407.10±99.24 281.87±76.38 p<0.001
Heart
(K/mg protein) 57.80±11.94 39.36±12.48 p<0.001
Data are presented as mean±SD. Each group contained 16 animals. The differences 
between groups were assessed by independent t-test. p < 0.05 considered signifi cant.
Sample Diabetic Control 
Group
Diabetic + 
ω-3 fatty 
Acids Group
t-test Results
Erythrocyte lysate
(K/mg Hb) 133.08±21.81 139.44±17.18 p=0.36
Liver  
(K/mg protein) 281.87±76.38 311.24±75.26 p=0.28
Heart
(K/mg protein) 39.36±12.48 46.43±12.25 p=0.11
Data are presented as mean±SD. Each group contained 16 animals. The differences 
between groups were assessed by independent t-test. p < 0.05 considered signifi cant.
Tab. 3. Values and the statistical comparison of catalase activity in 
diabetic control and diabetic + ω-3 fatty acids groups.
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Discussion 
This experimental study on STZ-induced diabetes mellitus 
revealed that catalase activity decreased substantially in the heart 
and liver while superoxide dismutase activity decreased in the 
heart. In addition, supplementation with vitamins increased the 
catalase activity in the heart of diabetic rats. Supplementation 
with ω-3 fatty acids made no signifi cant change in catalase activ-
ity. The catalase activity of liver and kidney is reported to be de-
creased in most of the current literature on diabetic subjects  (13, 
14). Glucose auto-oxidation, protein glycation, and interaction of 
advanced glycation end-products with their specifi c receptors on 
macrophages are the main mechanisms of increased production 
of oxygen free radicals in diabetes  (15, 16). In diabetic patients, 
the β oxidation of fatty acids increases as a result of insuffi cient 
insulin level, and causes accumulation of hydrogen peroxide in 
tissues, thus leading to enzyme inactivation through glycation pro-
cess. Since the concentration of hydrogen peroxide in the tissues 
is higher than that in the blood, the enzyme inactivation through 
glycation is more obvious in the tissues  (17). The lipid/protein 
ratio in the heart is higher than those in the liver and blood, and 
it might be the reason of higher level of β oxidation of fatty acids 
and hence higher level of hydrogen peroxide concentration which 
inactivates the enzymes of this tissue. It seems that applied vitamins 
act synergistically, and a combination of them provides a better ef-
fect. The ability of ascorbic acid to reduce α-tocopheroxyl radical 
to generate α-tocopherol and possibly to inhibit oxidation induced 
by α-tocopheroxyl radical has been demonstrated in many in vitro 
and in vivo studies  (18, 19). The synergistic effect of vitamins C, 
E and A could be expected based on the different environments 
where they act. Increased oxygen free radical production lowers 
the intracellular magnesium concentration and, in light of such 
evidence, vitamin E administration might also regulate the intra-
cellular magnesium level. Vitamin C acts in the hydrophilic mi-
lieu by scavenging reactive oxygen species  (20). However, in the 
hydrophobic domains of the bilayer, α-tocopherol and vitamin A, 
will inhibit the lipid oxidation free radical chain reaction, and Zn 
located in the interphase of the bilayer will prevent iron or copper 
binding to the membrane  (21, 22). Previously it has been reported 
that supplementation with vitamin E and vitamin C increases the 
activity of antioxidant enzymes  (23). Supplementation with ω-3 
fatty acids might also increase antioxidant enzymes activity  (24). 
Although the specifi c biologic mechanism for the benefi cial effects 
of ω-3 fatty acids on oxidative status has not been fully established, 
several data indicate that ω-3 fatty acids may play a key role in 
decreasing the complications of diabetes  (25, 26). 
In conclusion, the results of the present study indicated that 
in diabetic patients, a combination of vitamins may increase the 
activity of antioxidant enzymes by decreasing free radicals pro-
duction or inhibiting their oxidative damage. Further studies are 
needed to clarify the cellular mechanisms of this effect.
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